World Health Organisation. The evolving threat of antimicrobial resistance: options for action. WHO Press Geneva Switzerland (2012).
10.2174/15680266113139990011
10.1016/j.pep.2007.04.016
10.1016/j.ijmm.2007.10.005
10.3390/antibiotics2020182
10.1111/j.1751-1097.1991.tb02071.x
10.1016/S1011-1344(01)00207-X
10.1016/j.pdpdt.2009.10.008
Almeida A CunhaA FaustinoM ToméA NevesM. Porphyrins as antimicrobial photosensitizing agents. In: Photodynamic Inactivation of Microbial Pathogens: Medical and Environmental Applications. Hamblin M Jori G (Eds). Royal Society of Chemistry Cambridge UK 83–160 (2011).
10.1016/j.nano.2009.10.005
10.1016/j.chembiol.2005.08.014
10.1016/j.freeradbiomed.2013.07.031
10.1016/S1572-1000(05)00097-9
Nonell S , GonzalezM, TrullFR. 1H-phenalen-1-one-2-sulfonic acid-an extremely efficient singlet molecular-oxygen sensitizer for aqueous-media.Afinidad50(448), 445–450 (1993).
10.1615/JEnvironPatholToxicolOncol.v25.i1-2.20
10.1016/S0076-6879(00)19037-8
10.1529/biophysj.104.041434
Krasnovsky A Jr. Singlet molecular oxygen in photobiochemical systems: IR phosphorescence studies. Membr. Cell Biol.12(5), 665 (1998).
10.1016/1011-1344(90)85104-5
10.1016/S1011-1344(96)07428-3
10.1007/s10103-008-0539-1
Prasad PN . Introduction to Biophotonics. John Wiley and Sons NY USA (2004).
10.1111/j.1574-6968.1998.tb12908.x
10.1111/j.1574-695X.1997.tb01074.x
10.1358/dnp.2010.23.3.1444225
10.1002/(SICI)1096-9101(1996)18:3<253::AID-LSM6>3.0.CO;2-R
10.1101/cshperspect.a000414
10.1016/j.tim.2009.12.004
10.1111/j.1751-1097.1992.tb04213.x
10.1128/AAC.44.3.522-527.2000
10.1016/S0966-842X(97)81773-8
10.1016/S0003-9969(97)00062-9
10.1016/j.plipres.2009.06.002
10.1615/JEnvironPatholToxicolOncol.v25.i1-2.320
10.1146/annurev.micro.57.030502.090851
10.1371/journal.pone.0008385
10.1016/j.peptides.2012.05.025
10.1016/j.bbamem.2008.08.023
10.1007/s00249-012-0872-y
10.1016/j.bbamem.2007.10.024
Fiel RJ , Datta-GuptaN, MarkEH, HowardJC. Induction of DNA damage by porphyrin photosensitizers.Cancer Res.41(9 Part 1), 3543–3545 (1981).
10.1016/j.ccr.2004.02.004
10.2174/138945006778226561
Dutikova I , BorisovaO, ShchelkinaAet al. [5, 10, 15, 20-tetra-(N-methyl-3-pyridyl) porphyrin destabilizes the anti-parallel telomeric quadruplex d (TTAGGG) 4]. Molekuliarnaia biologiia 44(5), 929–937 (2009).
10.1007/s00249-012-0848-y
Cadet J DoukiT BadouardC FavierA RavanatJL. Oxidatively generated damage to cellular DNA: mechanistic aspects. In: Oxidative Damage to Nucleic Acids. Evans M Cooke M (Eds). Springer NY USA 1–13 (2007).
10.1111/j.1751-1097.1999.tb08240.x
10.1134/S0006297909120025
10.1016/j.bmc.2013.04.065
10.1111/j.1751-1097.2012.01080.x
10.1007/s00253-010-2747-4
10.1111/j.1751-1097.2012.01085.x
10.1111/j.1751-1097.2007.00244.x
10.1128/AAC.49.6.2329-2335.2005
10.1016/j.desal.2008.03.060
10.1016/j.pdpdt.2009.01.003
10.1016/j.freeradbiomed.2010.05.027
10.1111/j.1574-6968.2008.01413.x
10.1111/j.1574-6968.1993.tb06444.x
10.1016/j.jphotobiol.2013.06.007
10.1007/s11274-012-1125-z
10.1016/j.mimet.2011.05.021
10.1016/j.jphotobiol.2009.03.008
10.1111/j.1751-1097.2012.01154.x
Núñez SC RibeiroMS GarcezAS MiyakawaW. Assessment of photodynamic damage on Escherichia coli via atomic force microscopy. Presented at: SPIE Photonics Europe. Brussels Belgium 12–16 April 2010.
10.1016/S0167-7012(99)00048-2
10.1016/S0142-9612(02)00036-4
10.1128/AEM.69.11.6393-6398.2003
10.1146/annurev.biochem.78.081307.104803
10.1016/S0006-291X(03)00817-9
10.1016/j.jprot.2012.09.007
10.1016/S0304-4165(00)00071-4
10.1007/s00232-005-0753-8
10.1146/annurev.micro.57.030502.090938
10.1111/j.1601-1546.2012.00285.x
10.1016/j.jss.2013.03.094
10.1177/039139881003300909
10.1177/039139880803100914
10.1016/j.biomaterials.2009.02.038
10.1016/j.pdpdt.2012.12.001
10.1007/s00284-010-9629-y
10.1111/j.1751-1097.2010.00792.x
10.1111/j.1600-0765.2008.01187.x
10.1128/AAC.48.6.2173-2178.2004
Pedigo LA GibbsAJ ScottRJ StreetCN. Absence of bacterial resistance following repeat exposure to photodynamic therapy. 73803H–73803H (2009).
10.1111/j.1751-1097.1999.tb03320.x
10.1016/j.jphotobiol.2007.11.002
10.1016/S0300-9084(01)01258-5
10.1562/0031-8655(2000)072<0676:TEOPAO>2.0.CO;2
10.1016/j.pdpdt.2013.02.004
10.1111/j.1751-1097.2011.00902.x
10.1128/AAC.50.1.196-203.2006
10.1046/j.1523-1747.2000.00046.x
10.1016/S1011-1344(97)00057-2
10.1016/1011-1344(92)85108-7
10.1016/S1011-1344(99)00062-7
10.1111/j.1574-695X.2003.tb00644.x
10.1016/1011-1344(95)07249-7
10.1128/jb.175.5.1452-1456.1993
10.1128/jb.175.2.325-331.1993
10.1152/physiol.00054.2005
10.1128/jb.179.5.1828-1831.1997
Gaullier J -M, Berg K, Peng Q et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res.57(8), 1481–1486 (1997).
Kloek J , AkkermansW, HenegouwenGM. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.Photochem. Photobiol.67(1), 150–154 (1998).
10.1099/00222615-39-4-262
Nitzan Y MalikZ KauffmanM EhrenbergB. Induction of endogenic porphyrin production in bacteria and subsequent photoinactivation by various light sources. Presented at: BiOS Europe‘97. San Remo Italy 4–8 September 1997.
10.1111/j.1751-1097.1995.tb05279.x
10.1016/S1011-1344(97)00039-0
10.1111/j.1365-2672.2009.04341.x
10.1016/j.jphotobiol.2011.06.002
10.1016/j.ijantimicag.2010.03.002
10.1179/joc.2002.14.5.431
Brown S . Clinical developments in antimicrobial PDT. Presented at: 12th International Photodynamic Association World Congress Seattle. Seattle WA USA 11–15 June 2009.
10.1111/j.1365-2672.2009.04342.x
10.1016/j.mla.2009.07.004
